We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ALDMS market cap is 18.32M. The company's latest EPS is EUR -0.3871 and P/E is -3.59.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 25.19M | 33.54M | 33.25M | 38.51M | 35.55M |
| Operating Income | -4.57M | -2.89M | -3.57M | -1.92M | -4.4M |
| Net Income | -5.4M | -3.11M | -5.24M | -3.88M | -6.82M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 36.84M | 40.28M | 45.8M | 53.03M | 53.89M |
| Total Liabilities | 18.96M | 25.44M | 28.75M | 32.59M | 35.72M |
| Total Equity | 17.88M | 14.84M | 17.05M | 20.44M | 18.17M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -730k | 364k | -3.69M | -1.08M | 960k |
| Investing | -3.23M | -2.29M | 4.62M | -2.7M | -3.09M |
| Financing | 259k | 3.4M | 1.04M | 6.24M | 3.08M |
| Market Cap | 18.32M |
| Price to Earnings Ratio | -3.59 |
| Price to Sales Ratio | 0.69 |
| Price to Cash Ratio | 5.58 |
| Price to Book Ratio | 1.35 |
| Dividend Yield | - |
| Shares Outstanding | 17.62M |
| Average Volume (1 week) | 14.78k |
| Average Volume (1 Month) | 8.45k |
| 52 Week Change | -9.96% |
| 52 Week High | 1.60 |
| 52 Week Low | 0.794 |
| Spread (Intraday) | 0.03 (2.4%) |
| Company Name | Diagnostic Medical Systems |
| Address |
9 avenue du canal philippe lamour la garde, var 30660 |
| Website | https://www.dms.com |
| Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
